Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.36%
1,096.72
+3.98
+0.36%
—1,092.741,095.951,103.321,094.72——
SIXC
Communications
SIXC
Communications
SIXC
-0.33%
611.32
-2.04
-0.33%
—613.36613.36613.36609.50——
SIXE
Energy
SIXE
Energy
SIXE
-0.45%
1,171.54
-5.25
-0.45%
—1,176.791,176.521,182.251,166.69——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.45%
1,747.63
-7.91
-0.45%
—1,755.541,759.231,766.301,746.04——
SIXM
Financials
SIXM
Financials
SIXM
-0.58%
631.49
-3.66
-0.58%
—635.15635.20636.89630.09——
SIXR
Staples
SIXR
Staples
SIXR
+0.23%
849.94
+1.93
+0.23%
—848.01852.52855.78849.58——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.09%
218.06
+0.20
+0.09%
—217.86217.86219.52217.86——
SIXT
Technology
SIXT
Technology
SIXT
+3.47%
3,536.03
+118.68
+3.47%
—3,417.353,452.773,536.033,450.39——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.91%
905.07
-8.29
-0.91%
—913.36915.10920.43904.57——
SIXV
Health care
SIXV
Health care
SIXV
-0.86%
1,449.86
-12.52
-0.86%
—1,462.381,461.131,464.531,446.02——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.30%
2,430.47
+7.33
+0.30%
—2,423.142,428.712,448.692,424.63——
Q1 2026 earnings • released • EPS beat +14.69% • Revenue beat +1.01%
See results
EXEL:NASDAQ
Exelixis Inc
$48.16
+4.22%
(+1.95) 1D
$48.16
0.00% (0.00)
After hours
Closed: May 8, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EXEL...
Open
$46.59
High
$48.17
Low
$46.46
Mkt. cap
12.11B
Avg. vol.
2.55M
Volume
2.18M
P/E ratio
15.96
52-wk high
$49.40
52-wk low
$33.76
EPS
$3.02
Beta
0.38
Shares outstanding
251.36M
No. of employees
1K
News stories
From sources across the web
Profile
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration for medullary thyroid cancer with clinical activity in several other types of metastatic cancer. Wikipedia
About Exelixis Inc
CEOMichael M. Morrissey
Employees1.08K
FoundedNov 15, 1994
HeadquartersAlameda, California, United States
SectorBiotechnology
Websiteexelixis.com
Last report
May 5, 2026
Fiscal Period
Q1 2026
EPS / Est. (USD)
$0.87 / $0.76
+14.69%beat
Revenue / Est. (USD)
610.81M / 604.72M
+1.01%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
568.26M
597.76M
598.66M
610.81M
Cost of goods sold
19.47M
18.57M
26.48M
19.95M
Cost of revenue
19.47M
18.57M
26.48M
19.95M
Research and development expenses
200.36M
199.16M
213.25M
199.92M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
134.86M
123.66M
123.02M
139.60M
Operating expense
335.22M
322.82M
336.27M
339.52M
Total operating expenses
354.68M
341.40M
362.75M
359.47M
Operating income
213.58M
256.36M
235.91M
251.34M
Other non operating income
50.00K
-49.00K
46.00K
219.00K
EBT including unusual items
230.42M
252.41M
252.69M
267.69M
EBT excluding unusual items
230.42M
272.23M
253.38M
267.69M
Income tax expense
45.57M
58.84M
8.16M
57.22M
Effective tax rate
19.78%
23.31%
3.23%
21.38%
Other operating expenses
-
-
-
-
Net income
184.85M
193.58M
244.53M
210.47M
Net profit margin
32.53%
32.38%
40.85%
34.46%
Earnings per share
0.75
0.78
0.94
0.87
Interest and investment income
16.79M
15.92M
17.43M
16.13M
Interest expense
-
-
-
-
Net interest expenses
16.79M
15.92M
17.43M
16.13M
Depreciation and amortization charges
-
-
-
-
EBITDA
220.92M
263.78M
242.86M
258.60M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer